Patents
More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
Patents for C07D - Heterocyclic compounds (10,420)
03/1988
03/16/1988EP0259818A2 Process for the preparation of perhalohydrocarbon hypochlorites
03/16/1988CN87106163A Compounds
03/15/1988US4731361 Alkeneamidocephalosporin esters
03/10/1988WO1988001621A1 4-aminoquinoline derivatives and their use as medicaments
03/10/1988WO1988000942A3 Sulfonate benzotriazoles and their use in polyamide
03/09/1988EP0259174A1 Derivatives of 4-aminoquinoline and their use as medicaments
03/09/1988CN87104995A Beta-lactam compound, method for preparing the same, medicinal composition for bacterially infectious disease therapy containing the same and intermediates for synthesis of the same
03/08/1988US4729985 Hypotensive agents
03/08/1988CA1233815A1 Substituted vinyl cephalosporins
03/02/1988EP0096720B1 Process for the preparation of B-[(2-methylpropoxy)-methyl]-N-phenyl-N-(phenylmethyl)-1-pyrrolidineethanamine
03/02/1988CN86105465A Novel quinaldinamide derivatives and their preparations
02/1988
02/24/1988EP0256326A1 N-(2-cyano-2-oximinoacetyl)-aminonitriles
02/24/1988EP0256181A1 Novel quinaldinamide derivatives and their preparations
02/23/1988US4727153 Oxadiazolyl intermediates
02/23/1988US4727070 3-Propenzl cephalosporin isomer separation process and derivative
02/16/1988US4725616 1,3-dicarboxamide-oxindoles as antiinflammatory agents
02/11/1988WO1988000942A2 Sulfonate benzotriazoles and their use in polyamide
02/09/1988US4724266 Pharmaceutical composition with antithrombotic activity
02/09/1988US4723984 1-hydroxyethyl-azole compounds and agricultural compositions
02/03/1988EP0255141A2 Combination of active agents comprising diltiazem and acetylsalicylic acid, their preparation as well as their use in the preparation of medicaments with a thrombocyte-aggregation inhibitory activity
02/02/1988US4722931 Muscle relaxants
01/1988
01/27/1988EP0254495A2 Beta-Lactam compound, method for preparing the same, medicinal composition for bacterially infectious disease therapy containing the same and intermediates for synthesis of the same
01/20/1988EP0253396A2 Process for preparing 5,6-substituted-2,4-quinazolinediamines and intermediates
01/20/1988CN87104166A Antihypertensive agent
01/14/1988WO1988000184A1 Surface active lactams
01/13/1988EP0252473A2 7 Beta-(substituted) amino-3-substituted cephalosporanic acids and esters
01/12/1988US4719218 Pyrrolo[1,2-a]imidazole and pyrrolo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitor
01/06/1988CN87104282A Cephalosporin compounds and processes for preparing the same
12/1987
12/30/1987WO1987007891A1 N-(2-substituted alkyl)-n'-[(imidazole-4-yl)alkyl]guanidine
12/29/1987US4716232 Intermediates for antibiotics
12/29/1987CA1230879A1 Esters of 3-(3-substituted-amino-2-hydroxypropoxy)-4- substituted-1,2,5-thiadiazole derivatives
12/23/1987EP0250172A2 Cephalosporin compounds & processes for preparing the same
12/22/1987US4714760 Antibiotics
12/16/1987EP0249223A2 Novel antihypertensive agent
12/08/1987US4711775 Antidandruff hair lotions and shampoos
12/08/1987CA1230126A1 Cyclohexenone derivatives and their use in controlling undersirable plant growth
12/08/1987CA1230113A1 Method for producing chemical compounds
12/02/1987EP0247764A1 4(5)-Substituted imidazole derivatives, and intermediates and processes for their preparation
11/1987
11/24/1987US4709023 Process for the preparation of 7-amino-3-(3-formamidopyridinium)methyl-3-cephem-4-carboxylate, and its use for the synthesis of β-lactam antibiotics
11/24/1987US4708955 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof
11/24/1987CA1229608A1 Herbicidally active substituted phenyl-sulfamoyl pyridyl or triazinyl ureas
11/17/1987CA1229348A1 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane for use in the treatment of diseases
11/10/1987US4705800 Difluorbenzodioxyl cyanopyrrole microbicidal compositions
11/03/1987CA1228850A1 Cephalosporin derivatives and a process for their preparation
10/1987
10/13/1987CA1228070A1 1-piperazinocarboxylates, process for their preparation and pharmaceutical compositions containing them
10/06/1987US4698336 Cephalosporin antibiotics
09/1987
09/29/1987CA1227492A1 Process for the preparation of a compound having anti- ulcer activity
09/29/1987CA1227490A1 ¬(3,4-METHYLENEDIOXY) PHENETHYL|-5-¬ 3- CARBOXAMIDO-4-HYDROXY)-.alpha.-HYDROXYBENZYL| PYRROLIDINES
09/24/1987WO1987005604A1 2-aminopurine derivatives and process for their preparation
09/23/1987EP0237573A1 Novel benzothiazine derivatives
09/22/1987US4695627 Cephalosporin deoxygenation process
09/22/1987CA1227139A1 Oral product for controlling gingivitis
09/16/1987EP0236329A1 Amino-salicylic acid derivatives and pharmaceutical compositions
09/16/1987CN87100978A Dihydrobenzofuran-and chromancarboxamide derivatives, processes for the preparation thereof and use thereof as neuroleptics
09/15/1987US4694024 Anticoagulant mixture
09/08/1987US4692516 Process for the manufacture of 3-pyridinium-methyl-cephalosporins
09/01/1987US4690706 Benzothiadiazinone dioxide derivatives and phenoxybutyric acid derivatives
08/1987
08/26/1987EP0233271A1 Process for preparing cephalosporin intermediates.
08/24/1987EP0221959A4 Removing and recovering plant polyphenols.
08/12/1987EP0231622A2 Inhibition of the 5-lipoxygenase pathway
08/12/1987CN87100139A Process of manufacture of 1,5-benzothiazepine derivates
08/11/1987US4686216 7-[2-(2-aminothiazol-4-yl)-2-oximino-acetamido-3-quaternary-ammonium-methyl-3-cephem-4-carboxylates
08/05/1987EP0231139A2 Dihydrobenzofurane and chromane carboxamide derivatives, processes for their preparation and their use as neuroleptics
08/05/1987EP0230863A2 Oxadiazinones
08/05/1987CN86108507A Thiadiazole antiviral agents
08/04/1987CA1225084A2 Substituted vinyl cephalosporins
07/1987
07/28/1987US4683227 Antibiotic derivatives of 7β-[2-(thiazol-4-yl)acetamide]-3-chloro-3-cephem-4-carboxylic acids and compositions and method of use thereof
07/28/1987US4683080 Microbiocidal compositions comprising an aryl alkanol and a microbiocidal compound dissolved therein
07/21/1987US4681883 Histamine H2 -antagonist oxazole and thiazole derivatives and compositions therefor
07/21/1987CA1224477A1 Process for preparing dialkyl propanediimidate dihydrohalides
07/21/1987CA1224458A1 Process for the preparation of cephem compounds
07/21/1987CA1224457A1 Process for the preparation of cephem compounds
07/21/1987CA1224416A1 Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin
07/15/1987CN86106602A Novel cephalosporin derivatives, processes for their preparation and pharmaceutical compositions containing them
07/14/1987US4680402 Benzoyl-phenyl-piperidine derivatives
07/14/1987US4680052 Herbicidal benzodisultam derivative, compositions and method of use therefor
07/08/1987CN86108467A Trycyclic pyridazopyridone derivatives
07/08/1987CN86107927A Esters of cefuroxime
07/08/1987CN86107595A Novel pharmacological compounds
07/07/1987US4678802 Antiarthritic
06/1987
06/30/1987US4677219 Substituted benzonitriles
06/24/1987EP0226282A2 Heterocyclic compounds and their preparation and use
06/24/1987EP0226196A2 Tricyclic pyridone derivatives
06/24/1987EP0226093A2 Process for the preparation of cefodizime
06/18/1987WO1987003586A1 Process for the preparation of 1-methylamino-quinoline-carboxylic acid derivatives
06/16/1987EP0225601A2 Azapropazone prevention of post-ischemic tissue damage
06/10/1987EP0225127A2 Esters of cefuroxime
06/10/1987EP0224938A2 Intermediates for the production of podophyllotoxin and related compounds and processes for the preparation and use thereof
06/02/1987US4670433 Oxadiazolyl imidazobenzodiazepine derivatives pharmaceutical compositions thereof, and method of treating therewith
05/1987
05/27/1987EP0223246A2 New cephem compounds and processes for preparation thereof
05/27/1987EP0223184A2 Cephalosporins, process for their preparation and their use as medicaments
05/27/1987CN86107947A Cephem compouds and processes for prepn thereof
05/26/1987US4668699 Novel HMG-CoA reductase inhibitors
05/26/1987US4668676 Azapropazone prevention of post-ischemic tissue damage
05/20/1987EP0222322A2 Cephalosporin derivatives and process for their preparation
05/20/1987EP0221959A1 Removing and recovering plant polyphenols.
05/20/1987CN85107472A Preparation of perhydrothiazepine derivative
05/20/1987CN85106982A Bicyclic compounds and process for preparing them
05/19/1987US4667028 Process for the preparation of cephem compounds
05/13/1987EP0221719A2 Novel cephalosporin derivatives, processes for their preparation and pharmaceutical compositions containing them